Integrity Alliance’s Royalty Pharma RPRX Stock Holding History

Integrity Alliance’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$547K	Buy	+9,377	New	+$553K	0.02%	535

Other funds holding RPRX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return

Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Integrity Alliance's RPRX Position: Q3 2026 in Review

Integrity Alliance opened a new position in Royalty Pharma (RPRX) in Q3 2026: 9,377 shares worth $547K. The stake represents 0.02% of the portfolio and ranks #535 among its holdings.

208 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

Integrity Alliance held 9,377 shares of Royalty Pharma worth $547K as of Q3 2026.
Royalty Pharma was a new Integrity Alliance position in Q3 2026.
Royalty Pharma made up 0.02% of Integrity Alliance's portfolio in Q3 2026, its #535 holding.
208 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Integrity Alliance's 13F filing for Q3 2026, filed 29 Oct 2026.